The epidermal growth factor receptor (EGFR) is considered a molecular target for the treatment of cancer due to its abnormal expression or activation in a variety of cancer cells, especially non-small-cell lung cancer (NSCLC), which accounts for 84% of lung tumors [1,2]. Here, EGFR is linked to cancer.